Ceftazidime Avibactam is an advanced antibiotic combination used to treat serious bacterial infections caused by multidrug-resistant (MDR) gram-negative bacteria. As antibiotic resistance continues to increase worldwide, healthcare professionals rely on this combination to manage infections that no longer...
Introduction Antibiotic resistance has become one of the most serious healthcare challenges worldwide. As bacteria continue to evolve, many commonly used antibiotics are losing their effectiveness, making infections more difficult to treat. Among the most concerning pathogens are...
Gram-negative bacteria are among the most clinically significant pathogens in modern medicine. They are responsible for a wide range of infections, from uncomplicated urinary tract infections (UTIs) to life-threatening bloodstream infections and hospital-acquired pneumonia. Over the past decade,...
Antibiotics have transformed modern medicine by making many bacterial infections treatable. However, over time, some bacteria have developed ways to resist these medicines. One of the most common resistance mechanisms is the production of beta-lactamase enzymes, which can...
Aztreonam and Avibactam is an important combination used in the management of selected drug-resistant Gram-negative bacterial infections. By combining the antibacterial activity of Aztreonam with the beta-lactamase inhibition provided by Avibactam, this therapy helps address specific bacterial resistance...
